| Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER T Yang, PJ Espenshade, ME Wright, D Yabe, Y Gong, R Aebersold, ... Cell 110 (4), 489-500, 2002 | 1232 | 2002 |
| Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant C Winkler, W Modi, MW Smith, GW Nelson, X Wu, M Carrington, M Dean, ... Science 279 (5349), 389-393, 1998 | 964 | 1998 |
| GIP and GLP‐1, the two incretin hormones: similarities and differences Y Seino, M Fukushima, D Yabe Journal of diabetes investigation 1 (1‐2), 8-23, 2010 | 679 | 2010 |
| Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins D Yabe, MS Brown, JL Goldstein Proceedings of the National Academy of Sciences 99 (20), 12753-12758, 2002 | 664 | 2002 |
| Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes A Nohturfft, D Yabe, JL Goldstein, MS Brown, PJ Espenshade Cell 102 (3), 315-323, 2000 | 420 | 2000 |
| Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol N Sever, BL Song, D Yabe, JL Goldstein, MS Brown, RA DeBose-Boyd Journal of Biological Chemistry 278 (52), 52479-52490, 2003 | 376 | 2003 |
| Japanese clinical practice guideline for diabetes 2016 M Haneda, M Noda, H Origasa, H Noto, D Yabe, Y Fujita, A Goto, T Kondo, ... Diabetology international 9, 1-45, 2018 | 357 | 2018 |
| Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis D Yabe, R Komuro, G Liang, JL Goldstein, MS Brown Proceedings of the National Academy of Sciences 100 (6), 3155-3160, 2003 | 357 | 2003 |
| Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: incretin actions beyond the pancreas Y Seino, D Yabe Journal of diabetes investigation 4 (2), 108-130, 2013 | 293 | 2013 |
| β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians D Yabe, Y Seino, M Fukushima, S Seino Current diabetes reports 15, 1-9, 2015 | 285 | 2015 |
| Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation D Yabe, Y Seino Progress in biophysics and molecular biology 107 (2), 248-256, 2011 | 264 | 2011 |
| DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries T Nakamura, P Ruiz-Lozano, V Lindner, D Yabe, M Taniwaki, Y Furukawa, ... Journal of Biological Chemistry 274 (32), 22476-22483, 1999 | 243 | 1999 |
| Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase M Horiguchi, T Inoue, T Ohbayashi, M Hirai, K Noda, LY Marmorstein, ... Proceedings of the National Academy of Sciences 106 (45), 19029-19034, 2009 | 198 | 2009 |
| Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas N Yamamoto, K Tanigaki, M Tsuji, D Yabe, J Ito, T Honjo Journal of molecular medicine 84, 37-45, 2006 | 198 | 2006 |
| Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER PJ Espenshade, WP Li, D Yabe Proceedings of the National Academy of Sciences 99 (18), 11694-11699, 2002 | 198 | 2002 |
| Incretin‐based drugs for type 2 diabetes: focus on East Asian perspectives Y Seino, H Kuwata, D Yabe Journal of diabetes investigation 7, 102-109, 2016 | 176 | 2016 |
| Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas J Fujikura, K Hosoda, H Iwakura, T Tomita, M Noguchi, H Masuzaki, ... Cell metabolism 3 (1), 59-65, 2006 | 143 | 2006 |
| Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus WD Strain, X Cos, M Hirst, S Vencio, V Mohan, Z Vokó, D Yabe, M Blüher, ... Diabetes research and clinical practice 105 (3), 302-312, 2014 | 135 | 2014 |
| Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial D Yabe, J Nakamura, H Kaneto, S Deenadayalan, A Navarria, M Gislum, ... The Lancet Diabetes & Endocrinology 8 (5), 392-406, 2020 | 130 | 2020 |
| Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols D Yabe, ZP Xia, CM Adams, RB Rawson Proceedings of the National Academy of Sciences 99 (26), 16672-16677, 2002 | 128 | 2002 |
Katsumi IizukaClinical Nutrition, Fujita health university在 fujita-hu.ac.jp 的电子邮件经过验证
